The Long Island Breast Cancer Study Project: Description of a Multi-Institutional Collaboration to Identify Environmental Risk Factors for Breast Cancer
Tóm tắt
The Long Island Breast Cancer Study Project is a federally mandated, population-based case-control study to determine whether breast cancer risk among women in the counties of Nassau and Suffolk, NY, is associated with selected environmental exposures, assessed by blood samples, self-reports, and environmental home samples. This report describes the collaborative project's background, rationale, methods, participation rates, and distributions of known risk factors for breast cancer by case-control status, by blood donation, and by availability of environmental home samples. Interview response rates among eligible cases and controls were 82.1% (n, = 1,508) and 62.8% (n = 1,556), respectively. Among case and control respondents who completed the interviewer-administered questionnaire, 98.2 and 97.6% self-completed the food frequency questionnaire; 73.0 and 73.3% donated a blood sample; and 93.0 and 83.3% donated a urine sample. Among a random sample of case and control respondents who are long-term residents, samples of dust (83.6 and 83.0%); soil (93.5 and 89.7%); and water (94.3 and 93.9%) were collected. Established risk factors for breast cancer that were found to increase risk among Long Island women include lower parity, late age at first birth, little or no breast feeding, and family history of breast cancer. Factors that were found to be associated with a decreased likelihood that a respondent would donate blood include increasing age and past smoking; factors associated with an increased probability include white or other race, alcohol use, ever breastfed, ever use of hormone replacement therapy, ever use of oral contraceptives, and ever had a mammogram. Long-term residents (defined as 15+ years in the interview home) with environmental home samples did not differ from other long-term residents, although there were a number of differences in risk factor distributions between long-term residents and other participants, as anticipated.
Tài liệu tham khảo
Carson R: Silent Spring. Houghton Mifflin, New York, 1962, pp 158–161
New York State Department of Health, Bureau of Cancer Epidemiology: Cancer Incidence and Mortality by County, 1992–1996, Vol I, New York State, 1999 (http://www.health. state.ny.us/nysdoh/cancer/volume1._htm)
Graham JD, Clemente K, Glass R: Breast cancer: what are the perceived risk factors? Harvard Center Risk Anal. 4(5): 1–2, 1996
Kelsey JL, Horn-Ross P: Breast cancer: magnitude of the problem. Epidemiol Rev 15: 7–16, 1993
Hunter D, Willett W: Diet and breast cancer risk. Epidemiol Rev 15: 110–132, 1993
Baron JA, La Vecchia C, Levi F: The antiestrogenic effect of cigarette smoking in women. Amer J Obstet Gynecol 162: 502–514, 1990
Palmer JR, Rosenberg LR: Cigarette smoking and the risk of breast cancer. Epidemiol Rev 15: 145–156, 1993
Sandler DP, Everson RB, Wilcox AJ: Passive smoking in adulthood and cancer risk. Am J Epidemiol 121: 37–48, 1985
Morabia A, Bernstein M, Heritier S, Khatchatrian N: Relation of breast cancer with passive and active exposure to tobacco smoke. Amer J Epidemiol 143: 918–928, 1996
Rosenberg LR, Palmer JR: Alcohol and the risk of breast cancer. Epidemiol Rev 15: 133–144 1993
Swanson CA, Coates RJ, Malone KE, Gammon MD, Schoenberg JB, Brogan DJ, McAdams M, Potischman NA, Hoover RN, Brinton LA: Alcohol consumption and breast cancer risk among women under age 45. Epidemiol 8: 231–237, 1997
John EM, Kelsey JL: Environmental risk factors for breast cancer. Epidemiol Rev 15: 157–162, 1993
Kelsey JL, Bernstein L: Epidemiology and prevention of breast cancer. Annu Rev Public Health 17: 47–67, 1996
Bernstein L, Ross RK: Endogenous hormones and breast cancer risk. Epidemiol Rev 15: 48–65, 1993
Pike MC, Spicer DV, Dahmoush L, Press MF: Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15: 17–35, 1993
Stevens RG: Electric power use and breast cancer: a hypo-thesis. Am J Epidemiol 25: 556–561, 1987
El-Bayoumy K: Environmental carcinogens that may be in-volved in human breast cancer etiology. Chem Res Toxicol 5: 585–590, 1992
Morris JJ, Seifter E: The role of aromatic hydrocarbons in the genesis of breast cancer. Med Hypoth 38: 177–184, 1992
Davis DL, Bradlow L, Wolff M, Woodruff T, Hoel DG, Anton-Culver H: Medical hypothesis: xenoestorgens as preventable causes of breast cancer. Environ Health Perspect 101: 372–377, 1993
Gammon MD, John EM: Recent etiologic hypotheses con-cerning breast cancer. Epidemiol Rev 15: 163–168, 1993
Adami H-O, Lipworth L, Titus-Ernstoff L, Hseish C-C, Hanberg A, Ahlborg U, Baron J, Trichopoulos D: Organo-chlorine compounds and estrogen-related cancers in women. Cancer Causes Cont 6: 551–566, 1995
Ahlborg UG, Lipworth L, Titus-Ernstoff L, Hsieh C-C, Hanberg A, Baron J, Trichopoulos D, Adami H-O: Organo-chlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol 25: 463–531, 1995
Houghton DL, Ritter L: Organochlorine residues and risk of breast cancer. J Amer Coll Toxicol 14: 71–89, 19
Hoffmann W: Organochlorine compounds: risk of non-Hodgkin's lymphoma and breast cancer? Arch Environ Health 51: 189–192
Stevens RG, Davis S: The melatonin hypothesis: electric power and breast cancer. Environ Health Perspect 104 (suppl 1): 135–140, 1996
Wolff MS, Collman GW, Barrett JC, Huff J: Breast cancer and environmental risk factors: epidemiological and experimental findings. Annu Rev Pharmacol Toxicol 36: 573–596, 1996.
Laden F, Hunter DJ: Environmental risk factors and female breast cancer. Annu Rev Publ Health 19: 101–123, 1998
Welp EA, Weiderpass L, Boffetta P, Vainio H, Vasama-Neuvonen K, Petralia S, Partanen TJ: Environmental risk factors of breast cancer. Scand J Work Environ Health 24: 3–7, 1998
Larson SP: Environmental chemicals and their role in breast carcinogenesis: suitability for inclusion in an epidemiological study. Unpublished Masters' Essay, Columbia University School of Public Health, 1997
Arcaro KF, O'Keefe PW, Yang Y, Clayton W, Gierthy JF: Antiestrogenicity of environmental polycyclic aromatic hydrocarbons in human breast cancer cells. Toxicology 133: 115–127, 1999
Millikan R, DeVoto E, Newman B, Savitz D: Studying environmental influences and breast cancer risk: suggestions for an integrated population-based approach. Breast Cancer Res Treat 35: 79–89, 1995
Newman B, Moorman PG, Millikan R, Qaqusg BF, Geradts J, Aldrich, Liu ET: The Carolina breast cancer study: integrating population-based epidemiology and molecular biology. Breast Cancer Res Treat 35: 51–60, 1995
Ambrosone CB, Freudenheim JL GS, Marshall JR, Vena JE, Brasure JR, Michalek AM, Laughlin R, Nemoto T, Gillenwater KA, Harrington AM: Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk. J Amer Med Assoc 276: 1494–1501, 1996
Kabat GC, Chang CJ, Sparano JA, Sepkovic DW, Hu X-P, Khalil A, Rosenblatt R, Bradlow HL: Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomark Prev 6: 505–509, 1997
Helzlsouer KJ, Selmin O, Huang HY, Strickland PT, Hoffman S, Alberg AJ, Watson M, Comstock GW, Bell D: Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer. J Nat Cancer Inst 90: 512–518, 1998
Gammon MD, Hibshoosh H, Terry MB, Bose S, Schoenberg JB, Brinton LA, Bernstein JL, Thompson WD: Cigarette smoking and other risk factors in relation to p53 protein expression in breast cancer among young women. Cancer Epidemiol Biomark Prev 8: 255–263, 1999
Moysich KB, Shields PG, Freudenheim JL, Schisterman EF, Vena JE, Kostyniak P, Greizerstein H, Marshall JR, Graham S, Ambrosone CB: Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiol Biomark Prev 8: 41–44, 1999
Gammon MD, Wolff MS, Neugut AI, Terry MB, Britton JA, Greenebaum E, Hibshoosh H, Levin B, Wang Q, Santella R: Treatment for breast cancer and blood levels of chlorinated hydrocarbons. Cancer Epidemiol Biomark Prev 5: 467–471, 1996
Gammon MD, Wolff MS, Neugut AI, Terry MB, Papadopoulos K, Levin B, Wang Q, Santella RM: Temporal variation in chlorinated hydrocarbons in healthy women. Cancer Epidemiol Biomark Prev 6: 327–332, 1997
Waksberg J: Sampling methods for random digit dialing. J Amer Statistic Assoc 73: 40–46, 1978
Slattery ML, Edwards SL, Caan BJ, Kerber RA, Potter JD: Response rates among control subjects in case-control studies. Ann Epidemiol 5: 245–249, 1995
Moorman PG, Newman B, Millikan R, Tse C-K, Sandler DP: Participation rates in a case-control study: the impact of age, race and race of interviewer. Ann Epidemiol 9: 188–195, 1999
Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L: A data-based approach to diet questionnaire design and testing. Amer J Epidemiol 124: 453–469, 1986
Block G, Woods M, Potosky A, Clifford C: Validation of a self-administered diet history questionnaire using multiple diet records. J Clin Epidemiol 43: 1327–1335, 1990
Potischman N, Swanson CA, Coates RJ, Weiss HA, Brogan DR, Stanford JL, Schoenberg JB, Gammon MD, Brinton LA: Dietary relationships with early onset (under age 45) breast cancer in a case-control study: influence of chemotherapy treatment. Cancer Causes Cont 8: 713–721, 1997
Schlesselman JJ: Case-Control Studies: Design, Conduct, Analysis. Oxford University Press, New York, 1982
Selvin S: Statistical Analysis of Epidemiologic Data. 2nd edn, Oxford University Press, New York, 1996
Hoffman S, Grisso JA, Kelsey JL, Gammon MD, O'Brien LA: Parity, lactation, and hip fracture. Osteopor Int 3: 171–176, 1993
Olson SH, Kelsey JL, Pearson TA, Levin B: Evaluation of random digit dialing as a method of control selection in case-control studies. Am J Epidemiol 135: 210–222, 1992
Millikan RC, Pittman GS, Newman B, Tse C-KJ, Moorman PG, Bell DA: N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomark Prev 7: 371–378, 1998
Beyea J, Hatch M: Geographic exposure modeling: a valuable extension of GIS for use in environmental epidemiology. Environ Health Perspect 107 (suppl 1): 181–190, 1999